Dr. Agarwal’s Health Care share price drops 8% after muted listing. Should you buy, sell or hold?
Dr. Agarwal’s Health Care shares debuted at ₹402 on the NSE and ₹396.90 on the BSE, with an 8% drop shortly after. Analysts ...
Indian Television Dot Com9h
Dr Agarwals Eye Hospital: Eyeing clever marketing with Sachin Tendulkar
MUMBAI: When you want to be heard, either do it subtly when there’s pin drop silence or yell out loud when others are also ...
Focus on eyes: Modern cataract surgery is a safe, effective procedure
Modern cataract surgery is a safe, effective procedure, but it wasn't always this way. The earliest record dates back to the fifth century BC.
CNET3h
Protecting Your Vision Made Easy: 6 Eye-Friendly Vitamins and Supplements That Help
These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take better care of your eyes.
ophthalmologytimes4h
FDA approves continuous delivery ranibizumab injection (Susvimo) for the treatment of diabetic macular edema
Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...
Business Wire1h
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Healio1h
FDA approves Susvimo for diabetic macular edema
The FDA approved Susvimo for the treatment of diabetic macular edema, according to a press release. The decision was supported by positive 1-year data from the phase 3 Pagoda study, in which Susvimo ...